NC
MDXG icon

Northpointe Capital’s MiMedx Group MDXG Stock Holding History

Northpointe Capital’s Portfolio MDXG Stock Details MDXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-262,110
Closed -$1.85M – 238
2013
Q2 		$1.85M Buy
+262,110
New +$1.83M 0.21% 110

Other funds holding MDXG

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
SCA
Summit Creek Advisors Minneapolis, Minnesota $487M AUM 11.23% 1-Year Est. Return
PCM
Parsons Capital Management Providence, Rhode Island $2.21B AUM 28.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
RFC
Russell Frank Company Seattle, Washington $56.9B AUM 2.13% 1-Year Est. Return

Northpointe Capital's MDXG Position: Q3 2013 in Review

Northpointe Capital sold out of MiMedx Group (MDXG) in Q3 2013, closing a stake of 262,110 shares — an estimated $1.85M sold.

Northpointe Capital first reported a position in MDXG in Q2 2013 and held it in 1 quarter. The position peaked at $1.85M in Q2 2013. 82 funds tracked by Wall St. Rank hold MDXG as of Q3 2013.

  • Northpointe Capital reported no remaining MiMedx Group position as of Q3 2013 after selling out during the quarter.
  • Northpointe Capital sold 262,110 MiMedx Group shares in Q3 2013, an estimated $1.85M.
  • Northpointe Capital first reported a position in MiMedx Group in Q2 2013 and held it in 1 quarter.
  • Northpointe Capital's MiMedx Group position peaked at $1.85M in Q2 2013.
  • 82 funds tracked by Wall St. Rank held MiMedx Group as of Q3 2013.

Based on Northpointe Capital's 13F filing for Q3 2013, filed 7 Nov 2013.